The Clinical Value of Controlled Attenuation Parameters in Autoimmune Liver Diseases

Rui Zhang; Lina Cui; Ying Han

doi:10.47297/wspbdsWSP2752-630507.20260601

PDF
Export
Share
Collection
Album

The Clinical Value of Controlled Attenuation Parameters in Autoimmune Liver Diseases

Volume 6, Issue 1

Views: 0 Downloads: 0

The Clinical Value of Controlled Attenuation Parameters in Autoimmune Liver Diseases
The Clinical Value of Controlled Attenuation Parameters in Autoimmune Liver Diseases
1.Xi'an Medical University, Xi'an, 710021, Shaanxi, China
2.State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, The Air Force Military Medical University, Xi'an, Shaanxi, 710032, China
Vol. 6, Issue 1, Pages: 31-32(2026)
Published：30 March 2026
DOI：10.47297/wspbdsWSP2752-630507.20260601
Accepted：

Scan QR Code

Zhang Rui,Cui Lina,Han Ying.The Clinical Value of Controlled Attenuation Parameters in Autoimmune Liver Diseases[J].Biomedical Data Science,2026,06(01):31-32.
DOI：

Zhang Rui,Cui Lina,Han Ying.The Clinical Value of Controlled Attenuation Parameters in Autoimmune Liver Diseases[J].Biomedical Data Science,2026,06(01):31-32. DOI： 10.47297/wspbdsWSP2752-630507.20260601.

摘要

Abstract

This review assesses the utility of the Controlled Attenuation Parameter (CAP) in Autoimmune Liver Diseases (AILD). CAP demonstrates high diagnostic accuracy for hepatic steatosis in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis. However

in Autoimmune Hepatitis

active inflammation can depress CAP values

complicating its interpretation. Therefore

CAP use in AILD requires disease-contextualized understanding.

关键词

Keywords

references

Ginès P , Krag A , Abraldes J G , et al . Liver cirrhosis [J ] . Lancet (London, England) , 2021 , 398 ( 10308 ): 1359 - 1376 .

Zhang J , Lin S , Jiang D , et al . Chronic hepatitis B and non-alcoholic fatty liver disease: Conspirators or competitors? [J ] . Liver International: Official Journal of the International Association for the Study of the Liver , 2020 , 40 ( 3 ): 496 - 508 .

Huang S C , Liu C J . Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives [J ] . Clinical and Molecular Hepatology , 2023 , 29 ( 2 ): 320 - 331 .

Gaber Y , AbdAllah M , Salama A , et al . Metabolic-associated fatty liver disease and autoimmune hepatitis: an overlooked interaction [J ] . Expert Review of Gastroenterology & Hepatology , 2021 , 15 ( 10 ): 1181 - 1189 .

Hernández-Pérez M , Riado D , Pena E , et al . The overlap with metabolic dysfunction-associated steatotic liver disease negatively affects outcomes of primary biliary cholangitis [J ] . Alimentary pharmacology & therapeutics , 2024 , 60 ( 5 ): 613 - 619 .

Zhang Y , Meng F , Hu X , et al . Comparative diagnostic efficacy of two-dimensional shear wave and transient elastography in predicting the risk of esophagogastric varices and histological staging in patients with primary biliary cholangitis [J ] . BMC gastroenterology , 2024 , 24 ( 1 ): 396 .

Steinmann S , Hartl J , Weidemann S , et al . Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases [J ] . JHEP reports: innovation in hepatology , 2023 , 5 ( 12 ): 100898 .

Ni X X , Lian M , Wu H M , et al . Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases [J ] . World Journal of Gastroenterology , 2021 , 27 ( 1 ): 80 - 91 .

Alert me when the article has been cited

Submit

No data

Related Author

No data

Related Institution

No data

⁰